Pharmabiz22m
ALX Oncology to present results from phase 1b/2 trial of evorpacept in combo with zanidatamab at SABCS 2024
ALX Oncology to present results from phase 1b/2 trial of evorpacept in combo with zanidatamab at SABCS 2024: South San Francisco, California Tuesday, November 5, 2024, 12:00 Hrs [ ...
Pharmabiz1h
Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics
Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics: Houston Tuesday, November 5, 2024, 11:00 ...
Pharmabiz2h
Novo Nordisk announces positive results from phase 3 ESSENCE trial of semaglutide 2.4 mg to treat adults with MASH and liver fibrosis
Bagsværd, Denmark Tuesday, November 5, 2024, 10:00 Hrs [IST] ...
Pharmabiz3h
HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA-editing HG202 for macular degeneration
HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...
Pharmabiz4h
PLI & Ayushman Bharat initiatives will transform Indian pharma & healthcare sectors: Anil Matai
PLI & Ayushman Bharat initiatives will transform Indian pharma & healthcare sectors: Anil Matai: Nandita Vijayasimha, Bengaluru Tuesday, November 5, 2024, 08:00 Hrs [IST] The Dire ...
Pharmabiz4h
DGTR launches anti-dumping probe on calcium carbonate filler masterbatch imports from Vietnam
DGTR launches anti-dumping probe on calcium carbonate filler masterbatch imports from Vietnam: Shardul Nautiyal, Mumbai Tuesday, November 5, 2024, 08:00 Hrs [IST] India’s Direct ...
Pharmabiz4h
DHR invites applications for 2024-25 fellowships abroad
The Department of Health Research (DHR) under the ministry of health & family welfare, Government of India, is calling for applications from Indian scientists for short-term and long-term ...
Pharmabiz4h
DoP upholds ceiling price fixation for auto-immune disease drug azathioprine 50 mg
DoP upholds ceiling price fixation for auto-immune disease drug azathioprine 50 mg: Gireesh Babu, New Delhi Tuesday, November 5, 2024, 08:00 Hrs [IST] The Department of Pharmaceut ...
Pharmabiz18h
NIH study demonstrates long-term benefits of weight-loss surgery in young people
NIH study demonstrates long-term benefits of weight-loss surgery in young people: Bethesda, Maryland Monday, November 4, 2024, 18:00 Hrs [IST] Young people with severe obesity who ...
Pharmabiz19h
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...
Pharmabiz20h
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant: Rockville, Maryland Monday, November 4, 2024, 16:00 Hrs [IST] Ther ...
Pharmabiz20h
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...